Efficiency of Antiviral Therapy for Recurrence of Chronic Hepatitis C in Patients Undergoing Liver Transplantation
https://doi.org/10.22625/2072-6732-2013-5-3-35-38
Abstract
In the article the analysis data of observation and treatment recurrence hepatits C after liver transplantation. When performing operations on the background of the current active infection relapse is inevitable, and progression is fast. The effectiveness of antiviral therapy for immunosuppression is low. End-of-treatment response was achieved in 55,5%. Sustained virologic response was achieved in 42.9%. In one-third cases treatment was discontinuation because of adverse events.
About the Authors
A. A. Sukhoruk
Saint-Petersburg State Pediatric Medical University, Saint-Petersburg
Russian Federation
Russian Federation
E. V. Esaulenko
Saint-Petersburg State Pediatric Medical University, Saint-Petersburg
Russian Federation
Russian Federation
A. A. Yakovlev
Clinical Infectious Diseases Hospital named after S.P. Botkin, Saint-Petersburg
Russian Federation
Russian Federation
I. V. Khomchenko
Clinical Infectious Diseases Hospital named after S.P. Botkin, Saint-Petersburg
Russian Federation
Russian Federation
References
1. Ciccorossi, P. Viral load 1week after liver transplantation, donor age and rejections correlate with the outcome of recurrent hepatitis C / P. Ciccorossi [et al.] // Liver International. – 2007. – V. 27, Issue 5. – P. 612–619.
2. Seeff, L.B. Natural history of chronic hepatitis C / L.B. Seeff // Hepatology. – 2002. – V. 36, Issue suppl. 1. – P. S35–S46.
3. Alcántar, R. B. Treatment of hepatitis C before and after liver transplantation / R.B Alcántar. // Annals of Hepatology. – 2006. – V. 5, Suppl. 1. – P. S63–S66.
4. Berenguer, M. Natural history of clinically compensated hepatitis C virus–related graft cirrhosis after liver transplantation / M. Berenguer [et al.] // Hepatology. – 2000. – V. 32, № 4. – P. 852–858.
5. Yilmaz, N. A prospective evaluation of fibrosis progression in patients with recurrent hepatitis C virus following liver transplantation / N. Yilmaz [et al.] // Liver Transpl. – 2007. – V. 13. – P. 975–983.
6. Berenguer, M. Recurrent hepatitis C: worse outcomes established, interventions still inadequate / M. Berenguer // Liver Transpl. – 2007. – V. 13. – P. 641–643.
7. Roche, B. Hepatitis C virus treatment pre- and post-liver transplantation / B. Roche, D. Samuel // Liver Int. – 2012. – V. 32, Suppl. 1. – P. 120–128.
8. Terrault, N.A. Prophylactic and preemptive therapies for hepatitis C virus-infected patients undergoing liver transplantation / N.A. Terrault // Liver Transp1. – 2003. – V. 9, № 11, Suppl. 3. – P. S95–S100.
9. Berenguer, M. Spanish society of liver transplantation (SETH) consensus recommendations on hepatitis C virus and liver transplantation / M. Berenguer, [et al.] // Liver Int. – 2012. – V. 32, № 5. – P. 712–731.
10. Roche, B. Is early antiviral therapy for recurrent hepatitis C after liver transplantation superior to later treatment? The answer is no / B. Roche, D. Samuel // Liver Transplantation. – 2011. – V. 17, № 5. – P. 488–491.
11. Wang, C.S. Interferon-based combination anti-viral therapy for hepatitis C virus after liver transplantation: a review and quantitative analysis / C.S. Wang [et al.] // American Journal of Transplantation. – 2006. – V. 6. – P. 1586–1599.
12. Watt, K. A practical guide to the management of HCV infection following liver transplantation / K. Watt, B. Veldt, M. Charlton // American Journal of Transplantation. – 2009. – V. 9. – P. 1707–1713.
13. Dinges, S. Pegylated interferon-alpha2a/ribavirin treatment of recurrent hepatitis C after liver transplantation / S. Dinges [et al.] // Transpl. Infect. Dis. – 2009. – V. 11. – P. 33–39.
14. Sharma, P. Sustained virologic response to therapy of recurrent hepatitis C after liver transplantation is related to early virologic response and dose adherence / P. Sharma [et al.] // Liver Transpl. – 2007. – V. 13. – P. 1100–1108.
15. Otona, E. Hepatitis C recurrence after liver transplantation: viral and histologic response to full-dose peg- interferon and ribavirin / E. Otona [et al.] // American Journal of Transplantation. – 2006. – V. 6. – P. 2348–2355.
16. Gonzalez, S.A. Management of recurrent hepatitis C following liver transplantation / S.A. Gonzalez // Gastroenterology & Hepatology. – 2010. – V. 6, Issue 10. – P. 637–645.
17. Terrault, N.A. Treating hepatitis C infection in liver transplant recipients / N.A. Terrault, M. Berenguer // Liver Transpl. – 2006. – V. 12. – P. 1192–1204.
Review
For citations:
Sukhoruk A.A., Esaulenko E.V., Yakovlev A.A., Khomchenko I.V. Efficiency of Antiviral Therapy for Recurrence of Chronic Hepatitis C in Patients Undergoing Liver Transplantation. Journal Infectology. 2013;5(3):35-38. (In Russ.) https://doi.org/10.22625/2072-6732-2013-5-3-35-38
Views:
677
.png)
.png)
Email this article 